Wen, Yu-Ching
Tram, Van Thi Ngoc
Chen, Wei-Hao
Li, Chien-Hsiu http://orcid.org/0000-0002-4648-3744
Yeh, Hsiu-Lien
Thuy Dung, Phan Vu
Jiang, Kuo-Ching
Li, Han-Ru
Huang, Jiaoti http://orcid.org/0000-0003-1195-1998
Hsiao, Michael http://orcid.org/0000-0001-8529-9213
Chen, Wei-Yu
Liu, Yen-Nien http://orcid.org/0000-0002-3102-8482
Funding for this research was provided by:
National Health Research Institutes (NHRI-EX111-11109BI)
National Science and Technology Council, Taiwan
Article History
Received: 4 January 2023
Revised: 20 April 2023
Accepted: 25 April 2023
First Online: 4 May 2023
Change Date: 29 January 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41419-023-06363-1
Competing interests
: The authors declare no competing interests.
: Prostate tumor and sera samples from patients with BPH (23 samples), primary prostate cancer (16 samples), and CRPC (eight samples) were collected from the Taipei Medical University-Wan Fang Hospital (Taipei, Taiwan). Written informed consent was obtained from all the patients, and the study was approved by the Taipei Medical University Joint Institutional Review Board (approval no. N202201101), in accordance with the <i>Declaration of Helsinki</i>.